Imprese · 21/08/20191 min di lettura
Psychopharmacologic Drugs Advisory Committee; Cancellation
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The meeting of the Psychopharmacologic Drugs Advisory Committee scheduled for July 31, 2019, has been canceled. This meeting was announced in the Federal Register of June 14, 2019. This meeting has been canceled because of new information regarding the application. The Agency intends to continue evaluating the application and, as needed, will announce future meeting dates in the Federal Register.